US President Donald Trump announces deals with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs. Both companies „have agreed to offer their most popular GLP-1 weight-loss drug,“ Trump tells reporters at the White House, „at drastic discounts.“ SOUNDBITE